A detailed history of John G Ullman & Associates Inc transactions in Roche Hldg LTD Spons Adr stock. As of the latest transaction made, John G Ullman & Associates Inc holds 7,100 shares of RHHBY stock, worth $258,866. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,100
Previous 7,700 7.79%
Holding current value
$258,866
Previous $266,000 6.39%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$33.89 - $42.33 $20,334 - $25,398
-600 Reduced 7.79%
7,100 $283,000
Q2 2024

Aug 08, 2024

SELL
$29.26 - $35.71 $35,112 - $42,852
-1,200 Reduced 13.48%
7,700 $266,000
Q1 2024

May 06, 2024

SELL
$31.29 - $37.46 $21,903 - $26,222
-700 Reduced 7.29%
8,900 $284,000
Q4 2023

Jan 31, 2024

SELL
$32.33 - $36.23 $205,295 - $230,060
-6,350 Reduced 39.81%
9,600 $347,000
Q2 2023

Aug 21, 2023

BUY
$35.82 - $40.39 $93,132 - $105,014
2,600 Added 19.48%
15,950 $609,000
Q1 2023

May 05, 2023

SELL
$34.88 - $40.23 $95,920 - $110,632
-2,750 Reduced 17.08%
13,350 $479,000
Q4 2022

Feb 08, 2023

BUY
$39.15 - $43.25 $113,535 - $125,425
2,900 Added 21.97%
16,100 $630,000
Q3 2022

Oct 19, 2022

SELL
$38.69 - $42.93 $15,476 - $17,172
-400 Reduced 2.94%
13,200 $536,000
Q2 2022

Jul 27, 2022

BUY
$38.21 - $53.44 $59,225 - $82,832
1,550 Added 12.86%
13,600 $567,000
Q4 2021

Jan 26, 2022

BUY
$46.65 - $52.3 $76,972 - $86,295
1,650 Added 15.87%
12,050 $623,000
Q3 2021

Nov 02, 2021

SELL
$44.81 - $50.76 $2,240 - $2,538
-50 Reduced 0.48%
10,400 $473,000
Q2 2021

Jul 23, 2021

BUY
$40.63 - $47.81 $4,063 - $4,781
100 Added 0.97%
10,450 $491,000
Q1 2021

Apr 22, 2021

BUY
$40.12 - $45.7 $60,179 - $68,550
1,500 Added 16.95%
10,350 $420,000
Q4 2020

Feb 05, 2021

BUY
$39.99 - $44.25 $165,958 - $183,637
4,150 Added 88.3%
8,850 $388,000
Q2 2020

Jul 29, 2020

BUY
$39.39 - $45.61 $185,133 - $214,367
4,700 New
4,700 $204,000

Others Institutions Holding RHHBY

About ROCHE HLDG LTD SPONS ADR


  • Ticker RHHBY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 6,404,630,016
  • Market Cap $234B
More about RHHBY
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.